Source map — Roche’s GLP-1/GIP drug hits in phase 2 diabetes trial, fueling best-in-disease hopes
Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.
| Source | Type | Trust |
|---|---|---|
| WSJ | news | 60% |
| Reuters | news | 60% |
| Fierce Biotech | news | 60% |
| Endpoints News | news | 60% |
| FirstWord Pharma | news | 60% |
| www.lifeconverted.com | news | 50% |
| www.healthandme.com | news | 50% |
| www.xnxx.com | social | 50% |
| m-xnxx.com | social | 50% |
| xnxx.health | news | 50% |
| synapse.patsnap.com | news | 50% |
| navifyportal.roche.com | news | 50% |
| lifescience.roche.com | news | 50% |
| xnxx3.cc | news | 50% |
| ctv.veeva.com | news | 50% |
| www.discovmed.com | news | 50% |
| www.dietglp.com | news | 50% |
| onedaymd.aestheticsadvisor.com | news | 50% |
| glpchart.com | news | 50% |
| www.altrx.com | social | 50% |
| www.glp1authority.com | news | 50% |
| glp1briefing.com | news | 50% |
| www.ad-hoc-news.de | news | 50% |
| www.biospace.com | news | 50% |
| fr.wikipedia.org | news | 50% |
| diagnostics.roche.com | news | 50% |
| en.wikipedia.org | news | 50% |
| www.cnbc.com | news | 50% |
| medicalxpress.com | news | 50% |
| www.medscape.com | news | 50% |
| www.onedaymd.com | news | 50% |
| pharmaphorum.com | news | 50% |
| dadstrengthdaily.com | news | 50% |
| business-news-today.com | news | 50% |
| lifescivoice.com | news | 50% |
| www.clinicaltrialvanguard.com | news | 50% |
| finance.yahoo.com | news | 50% |